- Home
- OPHC vs VNRX Comparison
OPHC vs VNRX Comparison
Compare OPHC & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPHC
- VNRX
- Stock Information
- Founded
- OPHC 2000
- VNRX N/A
- Country
- OPHC United States
- VNRX United States
- Employees
- OPHC N/A
- VNRX N/A
- Industry
- OPHC Major Banks
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- OPHC Finance
- VNRX Health Care
- Exchange
- OPHC Nasdaq
- VNRX Nasdaq
- Market Cap
- OPHC 43.1M
- VNRX 45.2M
- IPO Year
- OPHC N/A
- VNRX N/A
- Fundamental
- Price
- OPHC $4.04
- VNRX $0.49
- Analyst Decision
- OPHC Hold
- VNRX Strong Buy
- Analyst Count
- OPHC 1
- VNRX 5
- Target Price
- OPHC $5.25
- VNRX $3.75
- AVG Volume (30 Days)
- OPHC 29.1K
- VNRX 310.7K
- Earning Date
- OPHC 05-12-2025
- VNRX 05-12-2025
- Dividend Yield
- OPHC N/A
- VNRX N/A
- EPS Growth
- OPHC 53.23
- VNRX N/A
- EPS
- OPHC 1.33
- VNRX N/A
- Revenue
- OPHC $37,091,000.00
- VNRX $1,233,511.00
- Revenue This Year
- OPHC N/A
- VNRX $812.84
- Revenue Next Year
- OPHC N/A
- VNRX $162.93
- P/E Ratio
- OPHC $3.04
- VNRX N/A
- Revenue Growth
- OPHC 60.44
- VNRX 59.10
- 52 Week Low
- OPHC $3.53
- VNRX $0.42
- 52 Week High
- OPHC $5.90
- VNRX $1.02
- Technical
- Relative Strength Index (RSI)
- OPHC 50.02
- VNRX 42.51
- Support Level
- OPHC $3.68
- VNRX $0.45
- Resistance Level
- OPHC $3.98
- VNRX $0.54
- Average True Range (ATR)
- OPHC 0.15
- VNRX 0.07
- MACD
- OPHC 0.03
- VNRX -0.00
- Stochastic Oscillator
- OPHC 80.95
- VNRX 33.33
About OPHC OptimumBank Holdings Inc.
OptimumBank Holdings Inc serves as a bank holding company for OptimumBank. The Bank provides a range of community banking services to individuals and corporate customers. Its services include demand interest-bearing and non-interest-bearing accounts, negotiable order of withdrawal account, money market deposit accounts, debit cards, and automated teller machines.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.